IRIS Accounts Production v26.1.10.61 07260218 Board of Directors 31.12.25 1.1.25 31.12.25 31.12.25 Medium entities These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. the provision of residential care services. true true true false true true false false false false false false true false A Ordinary 1.00000 B Ordinary 1.00000 C Ordinary 1.00000 D Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh072602182024-12-31072602182025-12-31072602182025-01-012025-12-31072602182023-12-31072602182024-01-012024-12-31072602182024-12-3107260218ns15:EnglandWales2025-01-012025-12-3107260218ns14:PoundSterling2025-01-012025-12-3107260218ns10:Director12025-01-012025-12-3107260218ns10:Consolidated2025-12-3107260218ns10:ConsolidatedGroupCompanyAccounts2025-01-012025-12-3107260218ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3107260218ns10:Consolidatedns10:MediumEntities2025-01-012025-12-3107260218ns10:Consolidatedns10:Audited2025-01-012025-12-3107260218ns10:Medium-sizedCompaniesRegimeForDirectorsReport2025-01-012025-12-3107260218ns10:Medium-sizedCompaniesRegimeForAccounts2025-01-012025-12-3107260218ns10:Consolidated2025-01-012025-12-3107260218ns10:Consolidatedns10:Medium-sizedCompaniesRegimeForDirectorsReport2025-01-012025-12-3107260218ns10:Medium-sizedCompaniesRegimeForAccountsns10:Consolidated2025-01-012025-12-3107260218ns10:FullAccounts2025-01-012025-12-3107260218ns5:Subsidiary12025-01-012025-12-3107260218ns5:Subsidiary22025-01-012025-12-3107260218ns5:Subsidiary32025-01-012025-12-310726021812025-01-012025-12-3107260218ns10:OrdinaryShareClass22025-01-012025-12-3107260218ns10:OrdinaryShareClass32025-01-012025-12-3107260218ns10:OrdinaryShareClass42025-01-012025-12-3107260218ns10:OrdinaryShareClass52025-01-012025-12-3107260218ns10:Director22025-01-012025-12-3107260218ns10:Director32025-01-012025-12-3107260218ns10:RegisteredOffice2025-01-012025-12-3107260218ns10:Consolidated2024-01-012024-12-3107260218ns5:CurrentFinancialInstruments2025-12-3107260218ns5:CurrentFinancialInstruments2024-12-3107260218ns5:Non-currentFinancialInstruments2025-12-3107260218ns5:Non-currentFinancialInstruments2024-12-3107260218ns5:ShareCapital2025-12-3107260218ns5:ShareCapital2024-12-3107260218ns5:RetainedEarningsAccumulatedLosses2025-12-3107260218ns5:RetainedEarningsAccumulatedLosses2024-12-3107260218ns5:ShareCapital2023-12-3107260218ns5:RetainedEarningsAccumulatedLosses2023-12-3107260218ns5:RetainedEarningsAccumulatedLosses2024-01-012024-12-3107260218ns5:RetainedEarningsAccumulatedLosses2025-01-012025-12-310726021812025-01-012025-12-3107260218ns5:NetGoodwill2025-01-012025-12-3107260218ns5:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3107260218ns5:FurnitureFittings2025-01-012025-12-3107260218ns5:MotorVehicles2025-01-012025-12-3107260218ns5:ComputerEquipment2025-01-012025-12-3107260218ns5:CostValuation2024-12-3107260218ns5:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-12-3107260218ns5:CostValuation2025-12-31072602181ns5:Subsidiary12025-01-012025-12-3107260218ns5:Subsidiary12025-12-3107260218ns5:Subsidiary12024-12-3107260218ns5:Subsidiary12024-01-012024-12-3107260218ns5:Subsidiary232025-01-012025-12-3107260218ns5:Subsidiary22025-12-3107260218ns5:Subsidiary22024-12-31072602185ns5:Subsidiary32025-01-012025-12-3107260218ns5:Subsidiary32025-12-3107260218ns5:Subsidiary32024-12-3107260218ns5:Subsidiary32024-01-012024-12-3107260218ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-3107260218ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3107260218ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2025-12-3107260218ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2024-12-3107260218ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2025-12-3107260218ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-12-3107260218ns5:Secured2025-12-3107260218ns5:Secured2024-12-3107260218ns10:OrdinaryShareClass22025-12-3107260218ns10:OrdinaryShareClass32025-12-3107260218ns10:OrdinaryShareClass42025-12-3107260218ns10:OrdinaryShareClass52025-12-3107260218ns5:RetainedEarningsAccumulatedLosses2024-12-31
REGISTERED NUMBER: 07260218 (England and Wales)















GROUP STRATEGIC REPORT, REPORT OF THE DIRECTORS AND

CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

FOR

NORTHGATE HEALTHCARE HOLDINGS LIMITED

NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)






CONTENTS OF THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025




Page

Company Information 1

Group Strategic Report 2

Report of the Directors 5

Report of the Independent Auditors 7

Consolidated Income Statement 11

Consolidated Other Comprehensive Income 12

Consolidated Balance Sheet 13

Company Balance Sheet 14

Consolidated Statement of Changes in Equity 15

Company Statement of Changes in Equity 16

Consolidated Cash Flow Statement 17

Notes to the Consolidated Cash Flow Statement 18

Notes to the Consolidated Financial Statements 19


NORTHGATE HEALTHCARE HOLDINGS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2025







DIRECTORS: A K Haines
K Haines
M K Haines





REGISTERED OFFICE: White Gables
Cross Lane Head
Bridgnorth
Shropshire
WV16 4SJ





REGISTERED NUMBER: 07260218 (England and Wales)





AUDITORS: Muras Baker Jones Limited
Chartered Accountants and Statutory Auditors
Regent House
Bath Avenue
Wolverhampton
West Midlands
WV1 4EG

NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)

GROUP STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025

The directors present their strategic report of the company and the group for the year ended 31 December 2025.

We aim to present a balanced, comprehensive review of our business's development and performance during the year and its position at year-end. Our review reflects the size and non-complex nature of our business and is written in the context of the risks and uncertainties we face.


NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)

GROUP STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025

REVIEW OF BUSINESS
Northgate Healthcare provides residential and nursing care homes for the elderly. We currently own and operate five homes across the Midlands. We manage and assess each home individually to ensure performance is measured effectively.

We pride ourselves on the quality of our homes and the care we provide. Across our five homes, we provide nursing, specialist dementia and residential care. Nursing care is provided at both Autumn House and Ashcroft Hollow, which also provide specialist dementia and residential care along with our other three homes.

As part of our growth strategy, we continue to explore acquisition opportunities. However, during 2025 we were unable to find a suitable acquisition that meets the Northgate ethos.

All homes were profitable in 2025 except our newest home, Ashcroft Hollow, which has been undergoing refurbishment when occupancy allows and results in 2026 are positive. The remainder of the homes and the group as a whole are profitable during 2026. Total turnover rose compared with 2024, driven by higher fees and occupancy rates.

We have continued the ongoing program of repairs to all homes to ensure they are kept to the high standards we continue to meet for all our service users. This has again resulted in a higher-than-average spend on repairs and maintenance at The Firs and Meadowfields, but it reflects the high standards we endeavour to maintain across the Northgate group. The refurbishment of Autumn House finished in 2025 with the home showing better occupancy as a result. The refurbishment of Ashcroft Hollow was ongoing during the year to ensure the home meets the high standards expected across the Northgate group. We expect overall maintenance expenditure to decrease across the other homes in 2026, apart from the usual cyclical refurbishment programme. We are planning an extension on Ashcroft Hollow for which planning has been granted and this is planned for the latter part of 2026 and 2027.

Nursing care is a growing sector within the industry and the directors are satisfied that including this service at both Autumn House and now Ashcroft Hollow is worthwhile to the Northgate Healthcare group. This will ensure Northgate Healthcare can continue to provide residents with the level of care they require as their needs change.

Our staff are at the heart of the care we provide and their dedication is central to our success. We recognise that attracting and retaining high-quality staff in the care sector remains a challenge. To support retention, we implemented wage increases in April 2025 and 2026 to remain competitive and to reward staff for their commitment. We also continue to invest in training and professional development to ensure our teams are skilled, motivated and able to deliver the highest standard of care. To ensure staff wellbeing remains a top priority, we offer a health and wellbeing programme for staff employed for over six months. This allows them 24/7 access to a GP and other support networks. This demonstrates our commitment to supporting the staff.

We are proud to maintain strong staff retention levels across our homes, which directly contributes to consistency of care, high resident satisfaction, and improved overall performance. By offering career progression, ongoing training and a supportive working environment, we ensure our workforce feels valued and engaged.

We consider the key financial performance indicators to be those that communicate the financial performance and strength of the company as a whole, these being average occupancy rates, gross profit margin and earnings before interest, tax, depreciation and amortisation (EBITDA).

Occupancy levels improved in 2025 compared with 2024 and we are confident that this trend will continue in 2026, particularly as Ashcroft Hollow continues to build occupancy throughout the year. Resident retention and satisfaction remain high across all homes.

The company's gross profit margin is similar to 2024, at 38.96% compared to 39.99% in 2024. This is a testament to both the high standards of the homes and the care provided to our residents.

Following the new measures introduced a couple of years ago, and which have continued since, this has helped achieve higher occupancy rates and better profitability across all homes in the group, with both occupancy rates and profitability increasing overall.


NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)

GROUP STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025

PRINCIPAL RISKS AND UNCERTAINTIES
The company continues to face a few external risks that could impact operations and financial performance, including:

- The effects of a further economic downturn, which could lead to further pressures on margins
- Changes in the availability of public sector funding, as a proportion of residents rely on government contributions to meet care fees.
- Changes to healthcare visas, which could lead to employment shortages throughout the sector.

With these risks and uncertainties in mind, we recognise that any plans for the future development of the business may be subject to unforeseen events outside our control.

FINANCIAL RISK MANAGEMENT
The company's credit risk is low, being primarily attributed to its trade debtors. The company manages all credit risk, both publicly and privately funded, by monitoring payments against contractual agreements. With interest rates continuing to fall during 2025, interest costs have been lower than in 2024, but loans were renegotiated during 2026, so we expect interest costs to fall further in the current year. This has supported profitability for the year and other measures have driven an overall increase in profitability for 2025. The directors continue to manage increased costs to support continued profitability.

The company faces financial risk from inflationary pressures on staff costs. Any future changes to the National Living Wage will significantly impact labour costs in the care sector as a whole. The company reviews upcoming changes to the National Living Wage and currently pays above this rate to ensure good quality care staff. The company plans future wage increases to support the company's financial stability and ensure these increases do not overly impact cash flow and profitability.

ON BEHALF OF THE BOARD:





A K Haines - Director


10 September 2026

NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 DECEMBER 2025

The directors present their report with the financial statements of the company and the group for the year ended 31 December 2025.

DIVIDENDS
Interim dividends per share were paid during the year as follows:
A Ordinary £1 - £5710.56
B Ordinary £1 - £9363.20
C Ordinary £1 - £4896.89
D Ordinary £1 - £12252.60
E Ordinary £1 - £3675.98
F Ordinary £1 - £3675.98

The total distribution of dividends for the year ended 31 December 2025 will be £ 681,419 .

FUTURE DEVELOPMENTS
The directors are confident about the continuing financial performance of the business and continue to seek opportunities to develop the business further.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 January 2025 to the date of this report.

A K Haines
K Haines
M K Haines

OUR PEOPLE
The company provides employees with information on matters of concern to them, consulting them regularly so that their views can be taken into account when making decisions that are likely to affect their interests.

Disabled employees
The company is committed to a policy of recruitment and promotion based on the basis of aptitude and ability without discrimination of any kind. Particular attention is given to the training and promotion of disabled employees to ensure that their career development is not unfairly restricted by their disability, or perceptions to it.

The HR procedures make clear that full and fair consideration must be given to applications made by and the promotion of disabled persons. Where an employee becomes disabled whilst employed by the company, the HR procedures also require that reasonable effort is made to ensure they have the opportunity for continued employment within the company. Retaining of employees who become disabled whilst employed by the company is offered where appropriate.

DISCLOSURE IN THE STRATEGIC REPORT
A review of the business, principle risks and uncertainties and financial risk management are included in the Strategic Report.


NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 DECEMBER 2025

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Group Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the group and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's and the group's transactions and disclose with reasonable accuracy at any time the financial position of the company and the group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the group's auditors are unaware, and each director has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the group's auditors are aware of that information.

AUDITORS
The auditors, Muras Baker Jones Limited, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





A K Haines - Director


10 September 2026

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
NORTHGATE HEALTHCARE HOLDINGS LIMITED

Opinion
We have audited the financial statements of Northgate Healthcare Holdings Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 December 2025 which comprise the Consolidated Income Statement, Consolidated Other Comprehensive Income, Consolidated Balance Sheet, Company Balance Sheet, Consolidated Statement of Changes in Equity, Company Statement of Changes in Equity, Consolidated Cash Flow Statement and Notes to the Consolidated Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the group's and of the parent company affairs as at 31 December 2025 and of the group's profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Group Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Group Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Group Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
NORTHGATE HEALTHCARE HOLDINGS LIMITED


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or
- the parent company financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page six, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the group's and the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or the parent company or to cease operations, or have no realistic alternative but to do so.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
NORTHGATE HEALTHCARE HOLDINGS LIMITED


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from
material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

In planning and designing our audit tests we identify and assess the risks of material misstatement within the financial
statements, whether due to fraud or error. Our assessment of these risks includes consideration of the nature of the
industry and sector, the control environment and the business performance along with the results of our enquiries of
management about their own identification and assessment of risks and irregularities. In common with all audits under ISAs (UK), we are also required to perform specific procedures to respond to the risk of management override. We also obtained an understanding of the legal and regulatory frameworks that the company operates in, focusing on provisions of those laws and regulations that had a direct effect on the determination of material amounts and disclosures in the financial statements. The key laws and regulations we considered in this context included the UK Companies Act, UK tax legislation and other laws and regulations identified as risk areas identified from our discussions with management.

We communicated relevant identified laws and regulations and potential fraud risks to all engagement team members including internal specialists, and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.

After consideration of the above risks we then carried out audit procedures including the following:

- specific tests in relation to material amounts and disclosures in the financial statements considered to be of high risk;
- performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud;
- reading minutes of management meetings;
- reviewing correspondence with H M Revenue & Customs;
- enquiring of management and reviewing any correspondence with legal advisors concerning actual and potential
litigation and claims;
- reviewing the financial statement disclosures and testing to supporting documentation to assess compliance with
provisions of relevant laws and regulations described as having a direct effect on the financial statements;
- in addressing the risk of fraud through management override of controls, testing the appropriateness of journal entries and other adjustments; assessing whether the judgements made in making accounting estimates are indicative of a potential bias; and evaluating the business rationale of any significant transactions that are unusual or outside the normal course of business.

There are inherent limitations in our audit procedures described above. The more removed that the laws and regulations are from financial transactions the less likely it is that we would be aware on non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any. Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditor's Report.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
NORTHGATE HEALTHCARE HOLDINGS LIMITED


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Nicky Gibbons BSc (Hons) FCA (Senior Statutory Auditor)
for and on behalf of Muras Baker Jones Limited
Chartered Accountants and Statutory Auditors
Regent House
Bath Avenue
Wolverhampton
West Midlands
WV1 4EG

10 September 2026

NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)

CONSOLIDATED
INCOME STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2025

2025 2024
Notes £    £   

TURNOVER 16,304,432 13,759,206

Cost of sales (10,427,602 ) (8,316,575 )
GROSS PROFIT 5,876,830 5,442,631

Administrative expenses (2,747,559 ) (2,486,646 )
OPERATING PROFIT 4 3,129,271 2,955,985

Interest receivable and similar income 18,373 31,650
3,147,644 2,987,635

Interest payable and similar expenses 5 (565,381 ) (550,930 )
PROFIT BEFORE TAXATION 2,582,263 2,436,705

Tax on profit 6 (652,504 ) (661,030 )
PROFIT FOR THE FINANCIAL YEAR 1,929,759 1,775,675
Profit attributable to:
Owners of the parent 1,929,759 1,775,675

NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)

CONSOLIDATED
OTHER COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2025

2025 2024
Notes £    £   

PROFIT FOR THE YEAR 1,929,759 1,775,675


OTHER COMPREHENSIVE INCOME
Revaluation surplus - (134,975 )
Income tax relating to other comprehensive
income

-

-
OTHER COMPREHENSIVE INCOME
FOR THE YEAR, NET OF INCOME TAX

-

(134,975

)
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

1,929,759

1,640,700

Total comprehensive income attributable to:
Owners of the parent 1,929,759 1,640,700

NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)

CONSOLIDATED BALANCE SHEET
31 DECEMBER 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 9 1,890,118 2,131,406
Tangible assets 10 16,770,120 16,628,799
Investments 11 - -
18,660,238 18,760,205

CURRENT ASSETS
Stocks 12 36,959 35,199
Debtors 13 969,205 1,080,255
Cash at bank and in hand 3,111,979 2,181,730
4,118,143 3,297,184
CREDITORS
Amounts falling due within one year 14 2,673,153 2,805,196
NET CURRENT ASSETS 1,444,990 491,988
TOTAL ASSETS LESS CURRENT
LIABILITIES

20,105,228

19,252,193

CREDITORS
Amounts falling due after more than one
year

15

(8,005,284

)

(8,413,745

)

PROVISIONS FOR LIABILITIES 19 (1,995,207 ) (1,982,051 )
NET ASSETS 10,104,737 8,856,397

CAPITAL AND RESERVES
Called up share capital 20 120 120
Revaluation reserve 21 4,468,122 4,468,122
Retained earnings 21 5,636,495 4,388,155
SHAREHOLDERS' FUNDS 10,104,737 8,856,397

The financial statements were approved by the Board of Directors and authorised for issue on 10 September 2026 and were signed on its behalf by:





A K Haines - Director


NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)

COMPANY BALANCE SHEET
31 DECEMBER 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 9 - -
Tangible assets 10 - -
Investments 11 2,638,421 2,696,459
2,638,421 2,696,459

CURRENT ASSETS
Debtors 13 44,188 -
Cash at bank - 289
44,188 289
CREDITORS
Amounts falling due within one year 14 795,534 805,081
NET CURRENT LIABILITIES (751,346 ) (804,792 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,887,075

1,891,667

CREDITORS
Amounts falling due after more than one
year

15

1,880,699

1,888,131
NET ASSETS 6,376 3,536

CAPITAL AND RESERVES
Called up share capital 20 120 120
Retained earnings 21 6,256 3,416
SHAREHOLDERS' FUNDS 6,376 3,536

Company's profit for the financial year 684,259 646,864

The financial statements were approved by the Board of Directors and authorised for issue on 10 September 2026 and were signed on its behalf by:





A K Haines - Director


NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2025

Called up
share Retained Revaluation Total
capital earnings reserve equity
£    £    £    £   
Balance at 1 January 2024 120 3,259,428 4,603,097 7,862,645

Changes in equity
Dividends - (646,948 ) - (646,948 )
Total comprehensive income - 1,775,675 (134,975 ) 1,640,700
Balance at 31 December 2024 120 4,388,155 4,468,122 8,856,397

Changes in equity
Dividends - (681,419 ) - (681,419 )
Total comprehensive income - 1,929,759 - 1,929,759
Balance at 31 December 2025 120 5,636,495 4,468,122 10,104,737

NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)

COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2025

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 January 2024 120 3,500 3,620

Changes in equity
Dividends - (646,948 ) (646,948 )
Total comprehensive income - 646,864 646,864
Balance at 31 December 2024 120 3,416 3,536

Changes in equity
Dividends - (681,419 ) (681,419 )
Total comprehensive income - 684,259 684,259
Balance at 31 December 2025 120 6,256 6,376

NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)

CONSOLIDATED CASH FLOW STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2025

2025 2024
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 3,437,866 3,944,291
Interest paid (552,742 ) (538,233 )
Interest element of hire purchase payments
paid

(12,639

)

(12,697

)
Tax paid (877,062 ) (589,279 )
Net cash from operating activities 1,995,423 2,804,082

Cash flows from investing activities
Purchase of intangible fixed assets 58,039 (2,696,398 )
Purchase of tangible fixed assets (389,660 ) (155,035 )
Interest received 18,373 31,650
Net cash from investing activities (313,248 ) (2,819,783 )

Cash flows from financing activities
New loans in year - 2,000,000
Loan repayments in year (452,094 ) (347,971 )
HP capital repayments in year 81,745 (30,309 )
Amount introduced by directors 300,563 -
Amount withdrawn by directors (721 ) (297,707 )
Equity dividends paid (681,419 ) (646,948 )
Net cash from financing activities (751,926 ) 677,065

Increase in cash and cash equivalents 930,249 661,364
Cash and cash equivalents at beginning of
year

2

2,181,730

1,520,366

Cash and cash equivalents at end of year 2 3,111,979 2,181,730

NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)

NOTES TO THE CONSOLIDATED CASH FLOW STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2025

1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM
OPERATIONS

2025 2024
£    £   
Profit before taxation 2,582,263 2,436,705
Depreciation charges 420,821 227,833
Loss on disposal of fixed assets 55,706 -
Adjustment to purchase price of Leacroft (44,938 ) -
Finance costs 565,381 550,930
Finance income (18,373 ) (31,650 )
3,560,860 3,183,818
Increase in stocks (1,760 ) (7,300 )
(Increase)/decrease in trade and other debtors (176,245 ) 251,907
Increase in trade and other creditors 55,011 515,866
Cash generated from operations 3,437,866 3,944,291

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 31 December 2025
31.12.25 1.1.25
£    £   
Cash and cash equivalents 3,111,979 2,181,730
Year ended 31 December 2024
31.12.24 1.1.24
£    £   
Cash and cash equivalents 2,181,730 1,520,366


3. ANALYSIS OF CHANGES IN NET DEBT

At 1.1.25 Cash flow At 31.12.25
£    £    £   
Net cash
Cash at bank and in hand 2,181,730 930,249 3,111,979
2,181,730 930,249 3,111,979
Debt
Finance leases (159,146 ) (81,745 ) (240,891 )
Debts falling due within 1 year (427,879 ) (24,215 ) (452,094 )
Debts falling due after 1 year (8,282,452 ) 476,309 (7,806,143 )
(8,869,477 ) 370,349 (8,499,128 )
Total (6,687,747 ) 1,300,598 (5,387,149 )

NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

1. STATUTORY INFORMATION

Northgate Healthcare Holdings Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the General Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Transactions between group entities which have been eliminated on consolidation are not disclosed within the financial statements.

Critical accounting judgements and key sources of estimation uncertainty
In order to properly apply the company's accounting policies, as described in note 1 above, the directors are required to make judgements and estimates in respect of carrying values of assets and liabilities which may not be apparent from other sources of information. The directors base these critical accounting judgements and estimations on previous historical experience and other factors which the directors judge to be relevant. Judgements and estimates will invariably differ from actual results and hence such judgements and estimates are reviewed by the directors on an ongoing basis.

Key sources of estimation uncertainty

The key sources of estimation uncertainty which have a significant effect on the amounts recognised in the financial statements are described below:

Property valuation
The care homes owned by the company have been revalued on a regular basis, the latest of these being based on professional valuations prepared in 2022 on two of the homes with the remaining two being in 2017. These have been reviewed each year by the directors. Although this complies with the relevant accounting standards there is a possibility that the realisable value of the homes may differ to the values used in the event of a sale.

Turnover
Turnover represents the fees derived from the provision of care services to residents during the year. Income is recognised on a daily basis for the provision of care services.

Goodwill
Goodwill, being the amount paid in connection with acquisition of care homes in 2007, 2010, 2015 and 2017 is being amortised evenly over its estimated useful economic life of 10 years. In addition goodwill on the purchase of Leacroft Lodge Limited purchased in 2024 is also being amortised evenly over its estimated useful economic life of 10 years. An annual impairment review has been carried out on the carrying value of goodwill and an adjustment is made where necessary.

Intangible assets
Intellectual property rights and books of account, being the amount paid in connection with the acquisition of a care home in 2010, are is being amortised evenly over its estimated useful economic life of 10 years. An annual impairment review has been carried out on the carrying value and an adjustment is made where necessary.

NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Fixtures and fittings - 15% on reducing balance and 10% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
i) Cash and cash Equivalents
Cash and cash equivalents are basic financial instruments and include cash in hand, deposits held at call with banks, and bank overdrafts.
(ii) Debtors and creditors receivable/payable within one year
Debtors and creditors with no stated interest rate and receivable or payable within one year are stated at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Consolidated Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The group operates a defined contribution pension scheme. Contributions payable to the group's pension scheme are charged to profit or loss in the period to which they relate.

NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

3. EMPLOYEES AND DIRECTORS
2025 2024
£    £   
Wages and salaries 8,842,600 7,152,643
Social security costs 730,077 494,275
Other pension costs 276,969 222,847
9,849,646 7,869,765

The average number of employees during the year was as follows:
2025 2024

Lane House 47 47
The Firs 99 113
Meadowfields 93 89
Autumn House 110 115
Leacroft Lodge 55 51
404 415

The average number of employees by undertakings that were proportionately consolidated during the year was 397 (2024 - 415 ) .

2025 2024
£    £   
Directors' remuneration 21,125 21,125
Directors' pension contributions to money purchase schemes 120,000 100,000

4. OPERATING PROFIT

The operating profit is stated after charging:

2025 2024
£    £   
Hire of plant and machinery 66,662 61,822
Other operating leases 6,000 5,200
Depreciation - owned assets 123,736 101,341
Depreciation - assets on hire purchase contracts 68,897 41,756
Loss on disposal of fixed assets 55,706 -
Goodwill amortisation 228,188 84,736
Auditors' remuneration 27,300 11,191

5. INTEREST PAYABLE AND SIMILAR EXPENSES
2025 2024
£    £   
Bank loan interest 552,742 534,359
Other interest - 3,874
Hire purchase 12,639 12,697
565,381 550,930

NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

6. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
2025 2024
£    £   
Current tax:
UK corporation tax 656,209 652,615
Amendment to prior year due to
capital allowances claim (16,861 ) -
Total current tax 639,348 652,615

Deferred tax 13,156 8,415
Tax on profit 652,504 661,030

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

2025 2024
£    £   
Profit before tax 2,582,263 2,436,705
Profit multiplied by the standard rate of corporation tax in the UK of 25 %
(2024 - 25 %)

645,566

609,176

Effects of:
Expenses not deductible for tax purposes 3,621 10,245
Capital allowances in excess of depreciation - (7,270 )
Depreciation in excess of capital allowances 42,374 -
Adjustments to tax charge in respect of previous periods (16,861 ) -
Deferred tax movement per note 19 13,156 8,415
Tax due relating to pre acquisition of subsidiary (35,352 ) 40,464
Total tax charge 652,504 661,030

Tax effects relating to effects of other comprehensive income

There were no tax effects for the year ended 31 December 2025.

2024
Gross Tax Net
£    £    £   
Revaluation surplus (134,975 ) - (134,975 )

7. INDIVIDUAL INCOME STATEMENT

As permitted by Section 408 of the Companies Act 2006, the Income Statement of the parent company is not presented as part of these financial statements.

The parent company's profit for the financial year was £684,259 (2024 - £646,864).

NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

8. DIVIDENDS
2025 2024
£    £   
A Ordinary shares of £1 each
Interim 171,316 167,948
B Ordinary shares of £1 each
Interim 93,632 86,013
C Ordinary shares of £1 each
Interim 146,906 147,948
D Ordinary shares of £1 each
Interim 122,526 109,000
E Ordinary shares of £1 each
Interim 110,279 102,029
F Ordinary shares of £1 each
Interim 36,760 34,010
681,419 646,948

9. INTANGIBLE FIXED ASSETS

Group
Patents
and
Goodwill licences Totals
£    £    £   
COST
At 1 January 2025 3,619,015 12,507 3,631,522
Other movement (13,100 ) - (13,100 )
At 31 December 2025 3,605,915 12,507 3,618,422
AMORTISATION
At 1 January 2025 1,487,610 12,506 1,500,116
Amortisation for year 228,188 - 228,188
At 31 December 2025 1,715,798 12,506 1,728,304
NET BOOK VALUE
At 31 December 2025 1,890,117 1 1,890,118
At 31 December 2024 2,131,405 1 2,131,406

NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

10. TANGIBLE FIXED ASSETS

Group
Fixtures
Freehold and Motor Computer
property fittings vehicles equipment Totals
£    £    £    £    £   
COST OR VALUATION
At 1 January 2025 15,761,143 2,104,716 271,122 26,714 18,163,695
Additions 56,284 152,795 168,818 11,764 389,661
Disposals - (169,877 ) - (10,358 ) (180,235 )
At 31 December 2025 15,817,427 2,087,634 439,940 28,120 18,373,121
DEPRECIATION
At 1 January 2025 114,619 1,266,043 135,864 18,370 1,534,896
Charge for year 9,931 101,802 76,019 4,881 192,633
Eliminated on disposal - (114,754 ) - (9,774 ) (124,528 )
At 31 December 2025 124,550 1,253,091 211,883 13,477 1,603,001
NET BOOK VALUE
At 31 December 2025 15,692,877 834,543 228,057 14,643 16,770,120
At 31 December 2024 15,646,524 838,673 135,258 8,344 16,628,799

Cost or valuation at 31 December 2025 is represented by:

Fixtures
Freehold and Motor Computer
property fittings vehicles equipment Totals
£    £    £    £    £   
Valuation in 2010 672,989 - - - 672,989
Valuation in 2013 979,584 - - - 979,584
Valuation in 2016 2,271,396 - - - 2,271,396
Valuation in 2022 1,906,817 - - - 1,906,817
Valuation in 2024 (163,227 ) - - - (163,227 )
Cost 10,149,868 2,087,634 439,940 28,120 12,705,562
15,817,427 2,087,634 439,940 28,120 18,373,121

If freehold land and buildings had not been revalued they would have been included at the following historical cost:

2025 2024
£    £   
Cost 10,149,868 10,093,584

NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

10. TANGIBLE FIXED ASSETS - continued

Group

Lane House Residential Care Home and The Firs Residential Care Home were revalued on an open market basis on 1st August 2024 by Colliers International Property Consultants Limited.

Meadowfields Residential Care Home and Autumn House Nursing Home were revalued on 7th October 2022 by Colliers International Valuation UK LLP.

The freehold properties were valued as fully equipped operational entities, having regard to their trading potential.

The property values were reviewed by the Directors as at 31 December 2025. The Directors have many years experience in the care home industry and therefore consider themselves in a proper position to make this review. In their opinion the market value of the all properties above has not materially altered since the date of the independent valuations.

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:
Motor
vehicles
£   
COST OR VALUATION
At 1 January 2025 222,702
Additions 150,318
At 31 December 2025 373,020
DEPRECIATION
At 1 January 2025 97,432
Charge for year 68,897
At 31 December 2025 166,329
NET BOOK VALUE
At 31 December 2025 206,691
At 31 December 2024 125,270

11. FIXED ASSET INVESTMENTS

Company
Shares in
group
undertakings
£   
COST
At 1 January 2025 2,696,459
Impairments (58,038 )
At 31 December 2025 2,638,421
NET BOOK VALUE
At 31 December 2025 2,638,421
At 31 December 2024 2,696,459

NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

11. FIXED ASSET INVESTMENTS - continued

The group or the company's investments at the Balance Sheet date in the share capital of companies include the following:

Subsidiaries

Northgate Healthcare Limited
Registered office: White Gables, Cross Lane Head, Bridgnorth WV16 4SJ
Nature of business: Residential care services
%
Class of shares: holding
Ordinary 100.00
2025 2024
£    £   
Aggregate capital and reserves 10,572,125 8,933,829
Profit for the year 2,449,715 1,919,626

Registered office address is the same as the parent company : White Gables Cross Lane Head Bridgnorth Shropshire WV16 4SJ

Southgate Healthcare Limited
Registered office: White Gables, Cross Lane Head, Bridgnorth WV16 4SJ
Nature of business: Dormant
%
Class of shares: holding
Ordinary 100.00
2025 2024
£    £   
Aggregate capital and reserves 1 1

Registered office address is the same as the parent company : White Gables Cross Lane Head Bridgnorth Shropshire WV16 4SJ

Leacroft Lodge Limited
Registered office: White Gables, Cross Lane Head, Bridgnorth WV16 4SJ
Nature of business: Residential care services
%
Class of shares: holding
Ordinary 100.00
2025 2024
£    £   
Aggregate capital and reserves 290,540 516,084
(Loss)/profit for the year (225,544 ) 99,183


12. STOCKS

Group
2025 2024
£    £   
Stocks 36,959 35,199

NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

13. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
2025 2024 2025 2024
£    £    £    £   
Trade debtors 929,976 720,673 - -
Amounts owed by group undertakings - - 44,188 -
Other debtors 20,759 17,047 - -
Directors' current accounts - 287,295 - -
Prepayments 18,470 55,240 - -
969,205 1,080,255 44,188 -

14. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
2025 2024 2025 2024
£    £    £    £   
Bank loans and overdrafts (see note 16) 452,094 427,879 51,682 95,889
Hire purchase contracts (see note 17) 41,750 27,853 - -
Trade creditors 516,094 515,837 - -
Amounts owed to group undertakings - - 731,390 695,011
Tax 255,365 493,079 - -
Social security and other taxes 181,108 141,656 - -
Other creditors 698,293 640,740 - -
Directors' current accounts 13,053 506 - -
Accrued expenses 515,396 557,646 12,462 14,181
2,673,153 2,805,196 795,534 805,081

15. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR

Group Company
2025 2024 2025 2024
£    £    £    £   
Bank loans (see note 16) 7,806,143 8,282,452 1,880,699 1,888,131
Hire purchase contracts (see note 17) 199,141 131,293 - -
8,005,284 8,413,745 1,880,699 1,888,131

NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

16. LOANS

An analysis of the maturity of loans is given below:

Group Company
2025 2024 2025 2024
£    £    £    £   
Amounts falling due within one year or on demand:
Bank overdrafts - - 22 -
Bank loans 452,094 427,879 51,660 95,889
452,094 427,879 51,682 95,889
Amounts falling due between one and two years:
Bank loans - 1-2 years 452,094 427,879 51,660 95,889
Amounts falling due between two and five years:
Bank loans - 2-5 years 5,679,989 6,349,997 154,979 287,666
Amounts falling due in more than five years:
Repayable by instalments
Bank loans more 5 yr by
instalments 1,674,060 1,504,576 1,674,060 1,504,576
1,674,060 1,504,576 1,674,060 1,504,576

17. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Group
Hire purchase
contracts
2025 2024
£    £   
Net obligations repayable:
Within one year 41,750 27,853
Between one and five years 199,141 131,293
240,891 159,146

Group
Non-cancellable
operating leases
2025 2024
£    £   
Within one year 19,904 23,667
Between one and five years 21,562 41,466
41,466 65,133

NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

18. SECURED DEBTS

The following secured debts are included within creditors:

Group Company
2025 2024 2025 2024
£    £    £    £   
Bank overdrafts - - 22 -
Bank loans 8,258,237 8,710,331 1,932,359 1,984,020
8,258,237 8,710,331 1,932,381 1,984,020

A first legal charge and debenture on freehold property known as Lane House, Lichfield Road, Tamworth, Staffordshire, The Firs, Wodehouse Lane, Sedgley, West Midlands, Meadowfields Residential Care Home, Great Haywood, Stafford and land on the north west and south east side of Pasturefields Lane, Great Haywood, Autumn House and Manor House, Stafford Road, Stone, Ashcroft Hollow, 18A Stafford Road, Huntington, Cannock and all other current and future assets exists in respect of secured debts in favour of National Westminster Bank PLC.

19. PROVISIONS FOR LIABILITIES

Group
2025 2024
£    £   
Deferred tax
Accelerated capital allowances 761,115 756,560
On revaluation of properties 1,199,436 1,199,436
Deferred tax 34,656 26,055
1,995,207 1,982,051

Group
Deferred
tax
£   
Balance at 1 January 2025 1,982,051
Accelerated capital allowances 13,156
Balance at 31 December 2025 1,995,207

20. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
30 A Ordinary £1 30 30
10 B Ordinary £1 10 10
30 C Ordinary £1 30 30
10 D Ordinary £1 10 10
30 E Ordinary £1 30 30
10 F Ordinary £1 10 10
120 120

NORTHGATE HEALTHCARE HOLDINGS LIMITED (REGISTERED NUMBER: 07260218)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

21. RESERVES

Group
Retained Revaluation
earnings reserve Totals
£    £    £   

At 1 January 2025 4,388,155 4,468,122 8,856,277
Profit for the year 1,929,759 - 1,929,759
Dividends (681,419 ) - (681,419 )
At 31 December 2025 5,636,495 4,468,122 10,104,617

Company
Retained
earnings
£   

At 1 January 2025 3,416
Profit for the year 684,259
Dividends (681,419 )
At 31 December 2025 6,256

The revaluation reserve is solely attributable to the revaluation of freehold property.

22. RELATED PARTY DISCLOSURES

Dividends totalling £681,419 (2024: £646,948) have been declared in respect of shares held by directors and their close family members.

23. ULTIMATE CONTROLLING PARTY

The company is jointly controlled by K Haines, A K Haines and M K Haines.